The National Institutes of Health notified Ossium that its proposal to demonstrate that the pool of viable, deceased donors for bone marrow transplants includes tissue donors -- deceased donors who do not satisfy all of the health requirements of organ donors -- is likely to be accepted. The NIH's decision... read more →
Position Summary: This Senior Cellular Therapy Technologist will provide technical support to programs within Ossium Health’s Manufacturing group relating to preparation of human bone marrow-derived materials for pre-clinical and clinical use. This work will involve executing and documenting the established methods as well as methods in development. It will also... read more →
Position Summary: This Cellular Therapy Technologist will provide technical support to programs within Ossium Health’s Manufacturing group relating to preparation of human bone marrow-derived materials for pre-clinical and clinical manufacturing. This work will involve executing and documenting methods for the manufacture of bone marrow-derived products. It will also involve the... read more →
Position Summary: The Quality Systems Manager will be responsible for ensuring compliance with all Federal and State regulations governing the manufacturing of cell therapy products. The QS Manager will oversee the production, distribution and review of documentation related to manufacturing and release testing of products; will ensure facilities and manufacturing... read more →
Leading Tissue Processor AlloSource has signed a decade-long strategic partnership with Ossium Health. The partnership combines a 10-year tissue processing relationship with a substantial financial investment. The deal is expected to radically accelerate the development of Ossium's bone marrow bank and bolster AlloSource's already large donor tissue processing operations with... read more →
Leading venture capital firm First Round Capital -- early investors in Uber, Square, Flatiron Health and more than 250 other companies -- has backed Ossium Health. The San Francisco, New York, and Philadelphia based VC specializes in early stage companies, pairing its "seed investments" with a suite of company-building services... read more →
Dr. Erik Woods -- former President of the International Society for Cryobiology, Founder, President and CEO of General Biotechnology, and SVP & Lead Scientist of Cook Regentec -- joined Ossium Health as Co-Founder and Chief Science Officer this month, rounding out Ossium's founding team with deep scientific expertise.